Compounds > ondansetron
Page last updated: 2024-11-01

ondansetron and Porphyria

ondansetron has been researched along with Porphyria in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Wet, M1
Jooste, R1
Coccia-Portugal, MA1
Falkson, G1

Other Studies

1 other study available for ondansetron and Porphyria

ArticleYear
Ondansetron in a patient with porphyria.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1992, Volume: 82, Issue:6

    Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Middle Aged; Ondansetron; Porphyrias

1992